External Urine Management Products Market (By Product: Male External Catheters, Female External Catheters; By Distribution Channel: Online, Offline; By End-use) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030.

The global external urine management products market was surpassed at USD 544.8 million in 2021 and is expected to hit around USD 844.5 million by 2030, growing at a CAGR of 4.99% from 2022 to 2030.

External Urine Management Products Market Size 2021 to 2030

Increasing incidence of Urinary Incontinence (UI), along with the need for effective and long-term solutions for the management of UI is anticipated to boost the market growth. An increasing number of incontinent patients is expected to boost the demand for external urine management products, thereby boosting the market growth during the forecast period. For instance, according to Phoenix Physical Therapy, over 200 million people are affected with urinary incontinence worldwide. Women are more susceptible to UI as compared to men due to hormonal changes, pregnancy, or menopause.

Rising initiatives by several market players to raise awareness regarding incontinence care globally are successfully breaking the stigma and taboo associated with it. For instance, the World Federation of Incontinence Patients (WFIP) introduced an annual initiative called World Continence Week with the approval of the International Incontinence Society. This initiative has been started at the global level to spread awareness related to UI, bladder weakness, and other conditions.Moreover, the outbreak of the COVID-19 has spurred the demand for incontinence products, such as external urinary catheters used in home settings. Since most consumers are aged/seniors, there is a higher demand for these products. Restrictions on movement at international borders have created an opportunity for local players to enter the market and meet the unmet demands of the end-users.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 544.8 million
Revenue Forecast by 2030 USD 844.5 million
Growth rate from 2022 to 2030 CAGR of 4.99%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Product, distribution channel, end-use, region
Companies Covered Hollister Inc.; Sage Products LC (Stryker); BD (C.R. Bard); Teleflex, Inc.; Consure Medical; Tilla Care, Inc.; B. Braun Melsungen AG; Boehringer Laboratories, LLC; Men’s Liberty (BioDerm); Coloplast Corp.; Sterimed Group; Cardinal Health

 

Product Insights

On the basis of products, the global market has been further divided into male external catheters, female external catheters, and urine collection accessories. The male external catheters segment dominated the global market in 2021 in terms of revenue share. The segment accounted for the largest revenue share of more than 65.06%. This segment is majorly driven by the rising prevalence of UI amongst men, increasing incidences of CAUTIs, primarily associated with indwelling catheters, as well as increased hospital admissions due to the rising cases of COVID-19 across the world. For many patients who prefer self-catheterization, male external catheters are the primary choice, in cases of UI/urine retention.

These catheters are also available in a variety of styles and sizes giving users many alternatives to choose from depending on their needs. This product is offered by a number of significant players, which is also projected to drive the segment during the projection period. Moreover, the female anatomy makes creating an external catheter for females more challenging. Since a male external catheter is easy and direct to use, its demand is comparatively high; this, in turn, is boosting the segment growth. However, the female external catheters segment is expected to grow at the fastest CAGR from 2022 to 2030.

Innovative products introduced by the top players in the market and increasing awareness about the treatment of incontinence amongst women are among the key factors driving the market growth. For instance, Tilla Care Inc., launched UriCap, an external urine collection device for managing female UI. In addition, UriCap Female can be recommended to elderly female patients suffering from COVID-19 as well as to staff. Also, in any healthcare or homecare situation, this product reduces the number of necessary care interactions associated with frequent diaper changes. Moreover, an increasing number of government initiatives to spread awareness about the urological disease, such as UI and distribution channel of external urinary catheters to prevent CAUTIs, is expected to have a positive impact on the segment during the forecast period.

Distribution Channel Insights

On the basis of distribution channels, the global market has been further bifurcated into the online and offline channels. The offline segment dominated the global market in 2021 and accounted for the largest share of more than 57.10% of the total revenue. The higher market share of the offline segment is credited to the long-established nature and widespread availability across the world. Moreover, the majority of the consumers still prefer shopping at offline distribution channels as it presents product verification, authenticity, and surety. In addition, offline stores offer convenience, customization, and personal assistance to the consumers, which, in turn, is anticipated to drive the segment growth.

Retail stores are the first point of contact for companies to supply products and samples. An increase in the retail business, which provides improved access to products, is anticipated to boost the segment growth over the forecast period. In addition, increasing customer sophistication and demand for better value are expected to create growth opportunities in the coming years.The online distribution segment is expected to expand at the fastest CAGR from 2022 to 2030. Factors, such as the availability of a wide range of products and attractive discounts, are anticipated to drive the segment growth over the forecast period. Moreover, the increasing availability of chatbots and FAQ pages helps customers with queries related to search, prescription, and other aspects of user experience.

This factor enhances the shopping experience for consumers. Higher flexibility offered, easier availability of products, and an increase in online purchasing through smartphones also support segment growth. External urinary catheters can be purchased at a low price via online platforms. Online channels can provide coupon benefits and other offers. Comfort, convenience, and easy payment are likely to drive the segment growth. Key online retailers include Amazon.com, Allegromedical.com, VitalityMedical.com, HealthProductsForYou.com, Shop Catheters, Purewickathome.com., and Catheter Deals Store.

End-use Insights

The hospitals segment dominated the global market in 2021 and accounted for the largest share of more than 43.00% of the overall revenue. The increasing number of surgical procedures performed and rising cases of end-stage renal diseases are the major driving factors of the segment. For instance, as per the report published by the CDC in 2016, in the U.S., around 125,000 people received treatment for end-stage kidney disease, whereas approximately 726,000 were on dialysis or had kidney transplants. Due to the recent outbreak of the COVID-19, there was an increase in hospital admissions, particularly among elderly patients. Older patients generally require urine management products on hospital admissions to avoid frequent movement, which is expected to drive the segment growth during the forecast period.

Moreover, the rising number of urological procedures and therapies is also one of the major driving factors. After the completion of any surgery, constant monitoring and care are necessary, owing to which, the demand for hospitals is increasing. For instance, according to the Urology Care Foundation, around 33 million people are living with an overactive bladder and a quarter to a third of men and women suffer from UI in the U.S. In addition, as per the Statistical Centers of National Spinal Cord Injury “Figure and Facts at a Glance 2020”, around 294,000 people in the U.S. are living with spinal cord injury, and around 17,810 people are diagnosed with spinal cord injury each year. Hospitals provide efficient and effective patient care, maintain a safe environment, and offer extensive services.

Thus, hospitals are expected to grow at a significant rate during the forecast period. Increasing adoption of home care services is expected to positively impact the market growth over the forecast period. Long-term care, cost-effectiveness, and prominent assistance services are major advantages of home care services. Patients undergoing home care generally use certain incontinence products, such as leakage pads, diapers, and external urinary catheters. Furthermore, the presence of several organizations offering home care services in North America and Europe is promoting the home care services market. According to Statistics Norway, around 32% of people aged 80 years & above used home care services in 2018. As a result, significant segment growth is expected during the forecast period.

Regional Insights

North America dominated the global market in 2021 with a revenue share of over 39.68% and is expected to witness a significant growth rate during the forecast period. The regional market is mainly driven by the rising incidence of targeted diseases, such as bladder obstruction, UI, Benign Prostate Hyperplasia (BPH), urinary retention, and bladder cancer. For instance, according to the American Academy of Family Physicians (AAFP), more than 250,000 patients with BPH undergo surgical procedures every year. This condition may occur due to aging or trauma/injury to the penis, urethra, or bladder, and is also associated with pregnancy.

The growing geriatric population, along with increasing life expectancy, has led to a larger number of patients undergoing surgeries is driving market growth in this region. Asia Pacific, on the other hand, is anticipated to register the fastest growth rate during the forecast period. The increasing prevalence of spinal cord injury, BPH, and UTI is driving the regional market. UTI is one of the most prevalent infectious diseases in this region. It is associated with significant morbidity and mortality rates, particularly in hospitals, and puts a substantial financial burden on the community. Thus, rising risks of UTI, particularly in women with increasing age, constipation, vaginal deliveries, parity, obesity, surgery, and chronic respiratory problems, such as cough, are driving the market in Asia Pacific.

Moreover, increasing government spending, high investment by key players, and awareness programs by various organizations are further expected to drive market growth during the forecast period. For instance, in India, the Urological Society of India drafted guidelines for spreading awareness about UI in the country. Similarly, the Korean Incontinence Society, in South Korea, is working towards spreading awareness about urology issues related to the pelvic floor and lower urinary tract. Thus, these factors are expected to boost the market growth in the Asia Pacific region during the forecast period.

Key Players

  • Hollister Inc.
  • Sage Products LC (Stryker)
  • BD (C. R. Bard)
  • Teleflex Inc.
  • Consure Medical
  • Tilla Care Inc.
  • B. Braun Melsungen AG
  • Boehringer Laboratories, LLC
  • Men’s Liberty (BioDerm)
  • Coloplast Corp.
  • Sterimed Group
  • Cardinal Health

Market Segmentation

  • By Product Outlook
    • Male External Catheters
    • Female External Catheters
    • Urine Collection Accessories
  • By Distribution Channel Outlook
    • Online
    • Offline
  • By End-use Outlook
    • Hospitals
    • Clinics
    • Home Care Settings
    • Others
  • By Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on External Urine Management Products Market 

5.1. COVID-19 Landscape: External Urine Management Products Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global External Urine Management Products Market, By Product

8.1. External Urine Management Products Market, by Product, 2022-2030

8.1.1 Male External Catheters

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Female External Catheters

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Urine Collection Accessories

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global External Urine Management Products Market, By Distribution Channel

9.1. External Urine Management Products Market, by Distribution Channel, 2022-2030

9.1.1. Online

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Offline

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global External Urine Management Products Market, By End-use 

10.1. External Urine Management Products Market, by End-use, 2022-2030

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Clinics

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Home Care Settings

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global External Urine Management Products Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.1.3. Market Revenue and Forecast, by End-use (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.1.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.1.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.2.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.2.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.2.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.2.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.2.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.3.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.3.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.3.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.3.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.3.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.4.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.4.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.4.6.3. Market Revenue and Forecast, by End-use (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.4.7.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.5.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.5.4.3. Market Revenue and Forecast, by End-use (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Distribution Channel (2017-2030)

11.5.5.3. Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12. Company Profiles

12.1. Hollister Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Sage Products LC (Stryker)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. BD (C. R. Bard)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Teleflex Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Consure Medical

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Tilla Care Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. B. Braun Melsungen AG

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Boehringer Laboratories, LLC

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Men’s Liberty (BioDerm)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Coloplast Corp.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers